Eupraxia Pharmaceuticals Inc.
EPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,744 | -$28,966 | -$18,991 | -$18,176 |
| Dep. & Amort. | $172 | $156 | $148 | $88 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,223 | $1,412 | $1,434 | $0 |
| Change in WC | -$6,765 | $5,352 | $1,515 | -$167 |
| Other Non-Cash | -$880 | $1,298 | $1,499 | $6,679 |
| Operating Cash Flow | -$29,994 | -$20,749 | -$14,395 | -$11,576 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$104 | -$73 | -$236 | -$341 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$3,272 | -$7,115 |
| Inv. Sales/Matur. | $0 | $0 | $13,342 | $0 |
| Other Inv. Act. | $29 | $0 | $0 | -$3,967 |
| Investing Cash Flow | -$75 | -$73 | $9,834 | -$11,424 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9,137 | -$79 | -$142 | $9,621 |
| Stock Issued | $54,559 | $15,887 | $10,637 | $29,911 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $363 | $5,272 | $307 | -$69 |
| Financing Cash Flow | $45,784 | $21,079 | $10,801 | $39,463 |
| Forex Effect | -$1,955 | $821 | -$507 | -$64 |
| Net Chg. in Cash | $13,760 | $1,078 | $5,733 | $16,399 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,342 | $18,263 | $12,531 | $118 |
| End Cash | $33,101 | $19,342 | $18,263 | $16,517 |
| Free Cash Flow | -$30,099 | -$20,822 | -$14,631 | -$11,917 |